力合科創(002243.SZ):持續通過概念驗證基金與中試基金向創新鏈早期延伸
格隆匯11月21日丨力合科創(002243.SZ)在投資者關係活動上表示,今年,公司投資孵化業務強化“更早、更小、更科技”的策略,並進一步聚焦科技成果轉化,投資了精準醫械、普太科技、禾思科技等企業,涵蓋磁共振導航手術機器人、鈣鈦礦電池、AOI檢測設備等硬科技領域;與重點高等院校、科研院所、新型研發機構廣泛開展戰略合作,與香港科技大學(廣州)簽訂成果轉化戰略合作協議,並轉化來自華南理工大學、深圳大學等高校院所的科技成果,挖掘水下機器人、多通道dToF信號皮秒精確測時芯片等早期優質項目。公司持續通過概念驗證基金與中試基金向創新鏈早期延伸,成功挖掘基因治療藥物開發、高功率密度液流電池、柔性壓力傳感器等多個前沿創新項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.